Anavex Life Sciences Corp (AVXL)

[TTTav66]

Fair enough, and I appreciate the reply. Personally, I tend to view the significant funding to be a rather prudent and timely move when facing the potential of a solo rare disease drug launch, but of course I can see how it could be viewed/utilized otherwise. I have no qualms with your 3 scenaris post, and appreciate maintaining a level approach. Cheers.